521 results on '"Arimondo, Paola B."'
Search Results
2. 3-Halo-3-nitro-aza/thioflavanones: DNMT inhibitors with a two-site binding mode in the hDNMT3A catalytic pocket
3. Inhibitors of DNA Methylation
4. Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum
5. High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells.
6. Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
7. Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
8. Anti-neoplastic and demethylating activity of a newly synthetized flavanone-derived compound in Renal Cell Carcinoma cell lines
9. Towards the sustainable discovery and development of new antibiotics
10. Chemical Compounds Targeting DNA Methylation and Hydroxymethylation
11. Supercomputer-Based Virtual Screening for Deoxyribonucleic Acid Methyltransferase 1 Inhibitors as Novel Anticancer Agents.
12. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells
13. The methylome of Biomphalaria glabrata and other mollusks: enduring modification of epigenetic landscape and phenotypic traits by a new DNA methylation inhibitor
14. Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells
15. Identification of novel quinazoline derivatives as potent antiplasmodial agents
16. Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors
17. Epidrugs as Promising Tools to Eliminate Plasmodium falciparum Artemisinin-Resistant and Quiescent Parasites
18. DAXX safeguards heterochromatin formation in embryonic stem cells
19. To target or not to target? The role of DNA and histone methylation in bacterial infections
20. DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies
21. Wandering along the epigenetic timeline
22. Telomerase Inhibitors Based on Quadruplex Ligands Selected by a Fluorescence Assay
23. Contributors
24. Targeting DOT1L for mixed-lineage rearranged leukemia
25. Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells.
26. DNA Methyltransferase Inhibitors: Development and Applications
27. Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches
28. A genetic screen identifies BEND3 as a regulator of bivalent gene expression and global DNA methylation
29. Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells
30. Epigenetic variation causes heritable variation in complex traits in the molluskBiomphalaria glabrata, vector of the human parasiteSchistosoma mansoni
31. Chemical Compounds Targeting DNA Methylation and Hydroxymethylation
32. The timeline of epigenetic drug discovery: from reality to dreams
33. Demethylation by low-dose 5-aza-2′-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma
34. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
35. An epigenetic molluscicide
36. Malaria Parasite Stress Tolerance Is Regulated by DNMT2-Mediated tRNA Cytosine Methylation
37. Plasmodium falciparum Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate Inhibitors
38. Data from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
39. Figure S1 from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
40. Supplementary Materials and Methods from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
41. Table S2 from A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
42. An epigenetic molluscicide
43. Design and synthesis of new non nucleoside inhibitors of DNMT3A
44. New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
45. EFMC - trends that link medicinal chemistry and chemical biology to translational drug discovery
46. EFMC – Trends that Link Medicinal Chemistry and Chemical Biology to Translational Drug Discovery
47. Design and Synthesis of Naturally-Inspired SARS-CoV-2 Inhibitors
48. Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 inPlasmodium falciparum
49. Cytisine-like alkaloids from Ormosia hosiei Hemsl. & E.H. Wilson
50. Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12 , 447.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.